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burnetii, the causative agent of Q fever
Gernot Schmoock1, Ralf Ehricht2 and Lisa D Sprague1*Abstract
Background: An easy-to-handle microarray assay based on the cost-effective ArrayTube™ platform has been
designed for the rapid and unequivocal identification of Coxiella burnetii, the causative agent of Q fever. The gene
targets include the chromosomally coded markers icd, omp/com1, and IS1111 as well as the plasmid coded markers
cbbE and cbhE.
Results: A representative panel comprising 50 German C. burnetii isolates and 10 clinical samples was examined to
validate the test. All tested isolates harboured plasmid QpH1 and were correctly identified, corresponding to 100%
sensitivity. The assay’s limit of detection was 100 genome equivalents (GE) for icd, omp/com1, cbbE and cbhE and 10
GE for IS1111. Assay specificity was 100% as determined by analysing a panel of 37 non-Coxiella strains.
Conclusions: The present array is a rational assembly of established and evaluated targets for the rapid and
unequivocal detection of C. burnetii. This array could be applied to the screening of vaginal swabs from small
ruminants; screening of environmental samples e.g. on farms or screening of human samples.
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The causative agent of the zoonosis Q fever, Coxiella
burnetii is listed by the United States Centers for Disease
Control and Prevention (CDC) as a Category B pathogen
and potential bioterrorism agent [1]. This small, Gram-
negative, nonmotile, obligate intracellular bacterium is
highly infectious and experimental data suggest that less
than 10 organisms can cause infection. In animals, infec-
tion takes mostly a subclinical or inapparent course but
abortions or birth of weak offspring, especially in small
ruminants, can occur [2,3]. In humans, the clinical pic-
ture can range from asymptomatic to severe, usually
presenting with fever, severe headache, myalgia and fa-
tigue, frequently accompanied by atypical pneumonia
and/or hepatitis. Chronic Q fever, i.e. persistence of in-
fection exceeding a period of six months duration, may
lead to endocarditis, which can be fatal. Additionally,
chronic hepatitis, osteomyelitis, and septic arthritis are
known sequelae [4].* Correspondence: lisa.sprague@fli.bund.de
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article, unless otherwise stated.Clinical diagnosis of C. burnetii infections in man and
animal usually relies on serology, despite molecular
methods such as PCR-based assays being more suitable
in terms of speed and specificity, especially within the
first couple of weeks after onset of disease [5-7]. How-
ever, although PCR assays are generally very fast and
sensitive, their multiplexing capacity is limited. More-
over, due to their high specificity, they are incapable of
detecting e.g. novel species or variants of a known spe-
cies [8]. Microarrays on the other hand can be designed
with a multitude of different probes either suitable for
species identification by using highly specific probes, or
for the detection of related or novel species by using
probes lying within conserved regions [8]. A further
benefit of the multiple targets on an array is that they
can partly mitigate the weakness of diagnostic PCR as-
says when the PCR primer target contains point muta-
tions. These mutations can be present in variants within
a species and can lead to false negative results.
In this study, we describe a microarray-based method
adapted to the ArrayTube™ (AT) platform, using three
chromosomal (icd, omp/com1, and IS1111) and two
plasmid (cbbE, cbhE) coded targets for the detection of
C. burnetii. This platform has repeatedly been shown totral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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Burkholderia mallei/pseudomallei, Brucella spp., Bacil-
lus anthracis, and Chlamydia spp. [9-12], for bacterial
species differentiation and genotyping [13] and for
automation-based applications.Methods
Cell culture and bacterial isolates
The heat inactivated preparations of C. burnetii isolates and
clinical samples used in this study were obtained from the
National Reference Laboratory of Q Fever at the Federal
Research Institute for Animal Health (Friedrich-Loeffler-
Institut (FLI), Jena, Germany) [14] (Table 1).Table 1 Panel of tested Coxiella isolates and clinical samples
Year Identifier Host Sample
1997 DP677 fallow deer isolate
1997 DP684 cattle isolate
1997 DP822 goat isolate
1998 DP682 goat isolate
1998 DP685 tick isolate
1998 DP751 sheep isolate
1998 DP752 sheep isolate
1998 DP759 tick isolate
1999 DP683 sheep isolate
1999 DP730 cattle isolate
2001 DP678 sheep isolate
2001 DP748 cattle isolate
2001 DP753 sheep isolate
2002 DP734 cattle isolate
2002 DP791 sheep isolate
2003 DP676 human isolate
2003 DP679 cattle isolate
2003 DP680 sheep isolate
2003 DP749 cattle isolate
2003 DP754 sheep isolate
2004 DP681 goat isolate
2004 DP731 sheep isolate
2004 DP732 sheep isolate
2004 DP733 sheep isolate
2004 DP735 cattle isolate
2005 DP698 sheep isolate
2007 DP819 cattle isolate
2008 DP750 cattle isolate
2008 DP756 goat isolate
2008 DP790 goat isolate
2008 DP816 sheep isolateAll non-Coxiella bacteria used in this study were ob-
tained from the German Collection of Microorganisms
and Cultures (DSMZ, Braunschweig, Germany), and from
the strain collection of the Institute of Bacterial Infections
and Zoonoses at the Federal Research Institute for Animal
Health (FLI, Jena, Germany). Bacteria were grown on
standard media under conditions recommended by the re-
spective bacterial strain collections. DNA from Bartonella
spp, Chlamydia spp, Francisella spp, Salmonella typhi-
murium, Haemophilus influenzae, and Legionella pneumo-
phila was obtained from the Institute for Medical
Microbiology and Infection Control, Goethe University,
Frankfurt/M., from the National Reference Laboratory of
Psittacosis, from the National Reference Laboratory ofisolated in Germany
Year Identifier Host Sample
2009 DP758 goat isolate
2009 DP792 sheep isolate
2009 DP795 sheep isolate
2009 DP798 sheep isolate
2009 DP801 sheep isolate
2009 DP804 sheep isolate
2009 DP807 sheep isolate
2009 DP810 sheep isolate
2009 DP813 sheep isolate
2010 12Q1649 cattle isolate
2011 12Q1650 sheep isolate
2011 12Q1651 sheep isolate
2011 12Q1652 sheep isolate
2011 12Q1653 sheep isolate
2011 12Q1654 sheep isolate
2011 12Q1655 sheep isolate
2011 12Q1656 sheep isolate
2012 12Q1657 cattle isolate
2012 12Q1658 cattle isolate
2008 15/24 sheep vaginal swab
2009 34/19 sheep vaginal swab
2009 34/23 sheep vaginal swab
2009 34/25 sheep vaginal swab
2009 34/51 sheep vaginal swab
2009 34/53 sheep vaginal swab
2009 34/54 sheep vaginal swab
2011 11Q3592 sheep vaginal swab
2012 12Q0778 sheep vaginal swab
2013 13Q2139 sheep vaginal swab
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of Salmonellosis at the FLI, Jena, from IDEXX in Ludwigs-
burg, and from the Institute for Medical Microbiology,
Jena, respectively (Table 2).
DNA extraction and quantification
Genomic DNA from inactivated preparations of C. burne-
tii isolates and from non-Coxiella bacteria was isolated
using the High Pure PCR Template Preparation Kit™
(Roche Diagnostics, Mannheim, Germany) according to
the manufacturer’s instructions. Quality and purity of
the DNA were determined using a Nanodrop ND-1000
spectrophotometer (PEQLAB Biotechnologie GmbH, Er-
langen, Germany). DNA quantification was performed
with a TaqMan based real-time PCR assay targeting the
transposase element IS1111 or the isocitrate dehydrogen-
ase gene (icd) as described by Klee et al. [15] and Hildeb-
randt et al. [16]. DNA quantification for NineMile
RSA493 was performed with the IS1111 real-time PCR
assay and genome equivalents (GE) were calculated with
20 IS1111 copies per genome. Priscilla Q177 DNA was
quantified with an icd real-time PCR assay and GE calcu-
lation was done with one icd copy per genome. Reaction
conditions have been described previously [16] with the
exception of the master mix (Maxima™ Probe qPCRTable 2 Panel of non-Coxiella strains used for specificity testi
Species Isolate
Actinobacillus pleuropneumoniae ATCC 27088
Bacillus cereus ATCC 10876
B. megaterium ATCC 14581
B. subtilis ATCC 6633
B. thuringiensis ATCC 10792
Bartonella henselae Marseille
B. quintana JK-31
Bordetella bronchiseptica ATCC 19395
Brucella abortus ATCC 23448
B. melitensis ATCC 23456
B. suis ATCC 23444
Burkholderia pseudomallei ATCC 23343
B. cepacia ATCC 25416
B. mallei ATCC 23344
Chlamydia psittaci C1/97
C. abortus 07 DC0059
Escherichia coli DSM 30083
Francisella tularensis subsp.
tularensis SchuS4/ FSC 237
F. tularensis subsp. holartica LVS/ FSC 155
ATCC: American Type Culture Collection; DSM: Deutsche Stammsammlung für MikroMaster Mix, Fermentas, St. Leon-Rot, Germany) and ther-
mocycler (Mx3000P Thermocycler, Agilent Technologies,
Santa Clara, CA, USA).
Primer and probe design
Gene specific primers and probes were designed and
optimised using the Array Design software package (Alere
Technologies GmbH, Jena, Germany) and the published
target sequences from the reference strains NineMile
RSA493 (GenBank: AE016828), Henzerling RSA331 and
Priscilla Q177. After design, all primers and probes were
blasted against the complete GenBank™ database (http://
www.ncbi.nlm.nih.gov/BLAST/).
Microarray layout and fabrication
Oligonucleotides were purchased as 3'-amino-modified
oligonucleotides from metabion (Martinsried, Germany)
and diluted in Spotting Buffer 1 (Quantifoil Micro Tools,
Jena, Germany) to a final concentration of 10 μM. Ar-
rays were spotted with six-fold redundancy on surface-
coated glass using Alere Technologies spotting machines
and assembled into array tubes as described previously
[17,18]. Internal staining controls (3’-amino and 5’-bio-
tin-modified oligonucleotides) were included for staining
control and orientation, as well as negative controlsng
Species Isolate
Haemophilus influenzae ATCC 9006
Klebsiella pneumoniae
subsp. pneumoniae DSM 30104
Lactobacillus ruminis DSM 20403
Legionella pneumophila
subsp. pneumophila DSM 7513
Mannheimia haemolytica ATCC 33396
Oligella urethralis DSM 7531
Pasteurella multocida DSM 5281
Proteus mirabilis DSM 4479
Pseudomonas aeruginosa ATCC 9027
P. alcaligenes ATCC 14909
P. fluorescens ATCC 13525
P. polymyxa ATCC 842
Rhodococcus equi DSM 20307
Salmonella typhimurium 9098
Staphylococcus aureus DSM 6732
Streptococcus equinus DSM 20558
S. parauberis DSM 6631
Yersinia enterocolitica
subsp. palearctica (Y 11) DSM 13030
organismen, Germany; FSC: Francisella Isolate Collection, Sweden.
Figure 1 Array layout, probe location, hybridisation patterns
and hybridisation images for Coxiella burnetii strains NineMile
RSA493, Priscilla Q177 and the non-template control (HPLC
grade H2O).
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Probe sequences and array layout are shown in Table 3,
and Figure 1, respectively.
PCR amplification of target genes and generation of
hybridisation control DNA
The 20 μL PCR reaction mixture contained 1 x 5 PRIME
HotMasterMix (VWR International GmbH, Darmstadt,
Germany), 0.3 μM forward primer, and 0.3 μM 5’-end bi-
otinylated reverse primer (icd: AT_ICD-F/R, omp/com1:
AT_Omp-F/R, IS1111: AT_IS-F/R, cbbE: AT_CbbE-F/R,
cbbE: AT_CbhE-F/R, Table 4). Amplifications were per-
formed using a Mastercycler ep® (Eppendorf, Germany).
The reaction was started with a 1 min denaturation step
at 96°C, followed by 35 cycles with 15 s of denaturation at
96°C, 20 s for annealing at 55°C, and 30 s for extension at
70°C. After a final 5 min extension step at 70°C the reac-
tion was stopped and the PCR products submitted to elec-
trophoresis. Hybridisation control DNA was generated
from 105 GE of the C. burnetii type strain (NineMile
RSA493) using the PCR conditions above and the primer
pair HybCtr-F (biotinylated) and HybCtr.
Hybridisation and data analysis
Hybridisation was carried out at 55°C for 60 min [10].
The hybridisation reaction was monitored using the
ATR-01™ array tube reader (Alere Technologies) at 25°C
for 10 min, recording one image at the end of incubation
time. Signal intensity data with local background correc-
tion were obtained using the Iconoclust™ software, ver-
sion 3.0 and Pionir/PARTISAN™ arrayLIMS software
(Alere Technologies GmbH). The normalised intensityTable 3 Sequences of oligonucleotide probes printed onto the microarray
Probe Target gene Sequence (5’→ 3’) Tm (°C) GC (%) Length (nt)
1a icd CCTGACCGACCCATTATTCCCTTTATCGAAGGAG 66,1 50,0 34
1b CCTGACCGACCCATTATTCCCTTTATCGAAGG 65,1 50,0 32
1c CCCATTATTCCCTTTATCGAAGGAGATGGGATTGG 64,9 46,0 35
2a omp/com1 CGTGGCGATAGCCGCCCCCTCTCAAT 69,3 65,0 26
2b CTCCTCAACAAGTCAAAGACATACAAAGCATCG 63,3 42,0 33
2c CAAAGCATCGTCCACCATTATTTAGTCAACC 62,0 42,0 31
3a IS1111 GTAAAGTGATCTACACGAGACGGGTTAAGCG 64,0 48,0 31
3b GCTCAGTATGTATCCACCGTAGCCAGTCTTAAG 64,6 48,0 33
3c CTGCGTGGTGATGGAAGCGTGTGGAG 66,9 62,0 26
4a cbbE CTAAGAAACTGCTTAAGAGAGGGCAGGGAACG 65,3 50,0 32
4b GGGCAGGGAACGATAGTGTGTTGCGGTATTTAC 67,3 52,0 33
4c CTTGAAAAACGTAGCGGAAAAGGGACAGTACG 65,0 47,0 32
5a cbhE GCTTATTTCGCCCTCGCTGACGGAAGAGGATC 68,6 56,0 32
5b CGGAAGAGGATCTTTTAGGTCGAATTAGACAGAGATAC 64,0 42,0 38
5c GCTGGGGGCCAAGAAAAGTTTGCAGACCAG 68,5 57,0 30
H HybCtr GACTTACCAACACATCAAAGTTCCCAGC 61,7 46,0 28
Table 4 Primers used for amplification of target genes and hybridisation control
Name Target gene Sequence (5’→ 3’) PCR product size (bp) Tm (°C) GC (%) Length (nt)
AT_ICD-F icd CGGAGTTAACCGGAGTATCCATC 178 57,6 52,0 23
AT_ICD-R GCATCGACCACGTTTTTCATG 56,2 48,0 21
AT_Omp-F omp/com1 GCACTATTTTTAGCCGGAACC 144 54,9 48,0 21
AT_Omp-R TGCTTCTACTAAAACTTCTGGG 53,0 41,0 22
AT_IS-F IS1111 CTGTGTGGAATTGATGAGTGG 142 54,2 48,0 21
AT_IS-R ACGTCCGATACCAATGGTTC 55,0 50,0 20
AT_CbbE-F cbbE TAAGGGACATCCACTACCGG 147 55,5 55,0 20
AT_CbbE-R CCCAAATTTAGATCGTCACATTG 53,6 39,0 23
AT_CbhE-F cbhE CGATGTCAACTCTAGAGAGC 147 52,5 50,0 20
AT_CbhE-R GCAATCTGCTCGGCAATAAAG 55,6 48,0 21
HybCtr-F ICD (HybCtr) CGGAGTTAACCGGAGTATCCATC 95 57,6 52,0 23
HybCtr-R AACTTCTAAAACGGCTTTATTAAC 51,5 29,0 24
Schmoock et al. Acta Veterinaria Scandinavica 2014, 56:27 Page 5 of 8
http://www.actavetscand.com/content/56/1/27(NI) was calculated for each spot using the following
equation: NI = 1-(M/BG), with M being the average in-
tensity of the recognised spot and BG the intensity of its
local background (Pionir/PARTISAN™ software). Values
<0.15 were considered negative, values ≥0.15 positive.
Determination of assay specificity and detection limit
In order to assess assay specificity, DNA from a panel of
37 type or in-house reference strains of different bacter-
ial origin was submitted to the above described PCR
procedure and subsequent hybridisation (Table 2). The
detection limit was the smallest amount of Coxiella
DNA detected by the test system for each individual tar-
get, and was determined in duplicate using tenfold serial
dilutions containing 105 to 100 genome equivalents (GE)
of NineMile RSA493 and Priscilla Q177, respectively.
Results
PCR amplification of target genes
Using the reference strains NineMile RSA493 (GenBank:
AE016828), Henzerling, and Priscilla Q177, five separate
PCR assays where established and optimised for each
target (Table 3). All gene targets were successfully ampli-
fied and the obtained fragment sizes corresponded to the
theoretical values (Table 4) calculated by in silico analysis
of the respective target sequences (data not shown).
Oligonucleotide probes and microarray layout
The selection of the microarray probe panel was based
on five well characterised genetic markers of C. burnetii.
The chromosomal target regions (icd, omp/com1, IS1111)
were chosen due to their genetic stability. The plasmid
coded target regions (cbbE, cbhE) were selected to identify
the Coxiella-specific plasmids QpRS and QpH1 [19,20].
After initial BLAST analysis, all available sequences for the
specific targets were used for sequence alignments. Thefinal microarray layout consisted of 16 oligonucleotide
probes of 26-38 bp in length with six-fold redundancy
(Figure 1).
Hybridisation results
Initially, hybridisation experiments were done with
three reference strains (Nine Mile RSA493, Henzerling
RSA331 and Priscilla Q177). Biotin-labelled amplifica-
tion products of every individual target were pooled and
applied to the array. The hybridisation patterns of all
three reference strains complied with two patterns;
these had been predicted from the in silico analysis of
target region sequences derived from the GenBank™ se-
quence database: pattern 1 for RSA493 and RSA331,
and pattern 2 for Q177, respectively (Figure 1).
In order to validate the new diagnostic assay, German
C. burnetii isolates obtained from the German Q-fever
network (http://www.fli.bund.de/de/startseite/institute/
institut-fuer-bakterielle-infektionen-und-zoonosen/pro-
jekte/bmbf-verbundprojekt-q-fieber.html), and from the
German National Reference Laboratory for Q fever were
tested; a sample panel of 50 different isolates and 10
clinical samples (vaginal swabs) collected in Germany
between 1997 and 2013 from sheep, goats, cattle, fallow
deer, ticks, and humans were applied to the array. All
analysed isolates revealed hybridisation signals corre-
sponding to pattern 1.
Determination of detection limits and assay specificity
The assay detection limit of every target was tested with
RSA493 and Q177 in serial dilutions of DNA. Every
marker was reliably detected down to DNA amounts of
100 genome equivalents (GE), whereby IS1111 detection
was more sensitive with a detection limit of 10 GE (data
not shown). The assay specificity was evaluated with 37
type or in-house reference strains of various bacterial
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hybridisation experiments with the test panel and in-
ternal hybridisation controls, thus confirming 100%
assay specificity.
Discussion
Diagnosis of Q fever in animal and man usually relies on
serological methods, such as indirect immunofluores-
cence, complement fixation or enzyme-linked immuno-
sorbent assays [5,21]. However, since C. burnetii-specific
antibodies only begin to appear several weeks after infec-
tion, diagnosis is delayed. DNA based diagnostic assays
are therefore more appropriate in terms of speed and
specificity, and a plethora of PCR assays suitable for the
detection of C. burnetii have been developed [15,22]. Al-
though these assays are usually fast and sensitive and
therefore more than adequate for most diagnostic appli-
cations, their capacity for multiplexing is limited [8].
This shortcoming has been resolved by using different
types of DNA microarrays which have proved to be suit-
able for a broad range of applications in the microbial
research and diagnostics of Q fever [7,23,24].
The microarray used in the present study was designed
to target the chromosomally coded single copy genes
isocitrate-dehydrogenase icd, the outer membrane protein-
coding gene omp/com1 and the transpoase gene in the
multi copy insertion element IS1111 as well as the plasmid
coded markers cbbE on QpRS and cbhE on QpH1. All
these markers have been characterised extensively and their
suitability as targets for detecting C. burnetii has been con-
firmed in numerous studies [19,25-29].
The analytical sensitivity of the assay used in the
present study was 100 GE for the single copy gene tar-
gets icd and omp/com1 as well as for the plasmid coded
targets cbbE and cbhE and 10 GE for the IS1111. Com-
parable values have been reported by Janse et al. [7], for
icd and IS1111 using suspension microarrays and for
IS1111 in a multiplex PCR targeting icd, omp/com1 and
IS1111 by de Bruin et al., [29]. The specificity of the
array was 100% with the tested non-Coxiella strains, in-
cluding the phylogenetic neighbours Legionella spp. and
Francisella spp. as well as with Bartonella spp. which
have been reported to cross react with Coxiella in sero-
logical assays [30]. We did not observe any cross reactions
between probes or primers and sample DNA as reported
by Janse et al. [7], which could be due to the different
oligonucleotide design and different array chemistry.
C. burnetii can harbour four different plasmids of dif-
ferent size and composition, namely QpH1, QpRS, QpDG,
QpDV and the chromosomally integrated plasmid-like se-
quences IPS [25,31,32]. Their role in the biology of C. bur-
netii is still not clear, but some plasmid genes appear to
be essential for conserved functions [33]. Moreover, a po-
tential influence of the different C. burnetii plasmids onanimal and human disease has been discussed [34]. Early
studies suggested that the plasmids QpH1 and QpRS are
markers for acute or chronic disease, respectively [32], but
this assumption could not be verified in a later study [35].
A small, recent study testing the hypothesis that obstetric
complications in C. burnetii infections were associated
with a particular genotype and the presence of QpDV,
found that this plasmid type was detected more frequently
in isolates associated with abortions [36]. All samples
tested in the present study originated from Germany and
harboured the plasmid QpH1. This plasmid type seems to
be the predominant type in the isolates circulating in
Germany and allegedly the Netherlands [14,36]. Since the
present array only includes probes for the plasmids QpH1
and QpRS, which currently appear to be the most fre-
quently occurring plasmid types in C. burnetii [14,35], the
existing array could be improved by implementing add-
itional probes for the other known plasmids of C. burnetii.
Several arrays have been developed for the detection
of C. burnetii [7,23,36,37]. These arrays range from easy-
to-handle, cheap but inflexible in terms of further probe
implementation, to highly sophisticated, expensive-on-
purchase but flexible regarding assay design. The Array-
Tube™ platform is an easy-to-handle, middle price range
(approx. 15 Euro/Array and PCR), molecular test for
high-throughput and parallel analysis of samples. Array
designs can be readily expanded by adding further gene
targets. Moreover, the modular composition of the plat-
form allows the rapid assembly of custom-made assays,
targeting different biological agents, e. g. as part of a
Bioweapon-agent-array detecting C. burnetii, Brucella
spp., B. mallei/pseudomallei, B. anthracis and Chlamydia
spp. [9-12].Conclusions
The present array is a rational assembly of established and
evaluated targets for the rapid and unequivocal detection
of C. burnetii. This array could be applied to the screening
of vaginal swabs from small ruminants, screening of envir-
onmental samples e.g. on farms, for screening patients
with infective endocarditis [38], or of blood donors in re-
gions of high endemicity for Q fever, e.g. the German-
Dutch border area, or in a diagnostic assay screening for
atypical pneumonias [23].Abbreviations
AT: Array tube; GE: genome equivalent; IS1111: Insertion element 1111;
icd: Isocitrate dehydrogenase; omp/com1: Outer membrane protein;
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